AT101, the R-(-)-enantiomer of Gossypol, is an inhibitor of antiapoptotic Bcl-2 family proteins, and might probably affect glioma cells that were in a dormant state due to TMZ treatment. This evidence concerns the gene BCL2 and central nervous system cancer.